The neurofilament light chain (NfL) level is correlated with the CNS inflammation in MS, with higher levels during acute relapse, but it is also helpful in assessing the neurodegenerative process, indicating the progression from relapsing–remitting MS (RRMS) to secondary progressive MS (SPMS). This evidence concerns the gene NEFL and myeloid sarcoma.